New method to prepare diagnostic medical radioisotope

New method to prepare diagnostic medical radioisotope
The investigation on preparation of LSA 99Mo/99mTc generator.  Credit: WANG Jieru and QIN Zhi

Researchers at the Institute of Modern Physics (IMP) of the Chinese Academy of Sciences (CAS) have conducted a study on preparation of low specific activity (LSA) 99Mo/99mTc generator, which has potential application prospect for the accelerator/reactor-based production of the medical isotope 99Mo.

99mTc, produced from the decay of its parent radioisotope 99Mo, is the most commonly used diagnostic medical radioisotope, comprising 80 percent of all diagnostic radionuclides. Annual worldwide demand for 99Mo is estimated to be approximately 500 thousand Ci, which provides diagnoses for about 30 million people. However, in China, the clinical 99Mo/99mTc generators are totally dependent on imports at present.

Currently, the production of 99Mo (a high specific activity of 104 Ci g-1) is mainly generated from (n, f) reaction in reactor using highly enriched uranium-235 target. Nevertheless, most of nuclear reactors are confronted with many issues, such as security, technique, overhauling, which cannot satisfy with the growing demand for 99Mo. Besides, the route of 99Mo separation is complex and a great amount of high-level radioactive waste liquid is produced during the process, increasing the probability of nuclear proliferation risk.

To make sure a reliable supply of 99Mo, accelerator/reactor-based production of 99Mo has been explored all over the world. Thus, it is of great importance to develop LSA 99Mo/99mTc generators using the column absorbents which has high absorption capacity for Mo ions, and achieve recycling of enriched Mo target.

The researchers from the Nuclear Chemistry Group of IMP have carried out an investigation on the synthesis of hierarchically macro/mesoporous γ-Al2O3 (HMMA), which is applied in the preparation of LSA 99Mo/99mTc generator.

Compared with the ordinary alumina (2–20 mg Mo per g of alumina), which is used for fission 99Mo/99mTc generator, HMMA exhibited high capacity to Mo ions with about 250 mg Mo per g of HMMA.

Furthermore, a LSA 99Mo generator prepared using HMMA as column matrix is capable of fine recovery of 99mTc (89 percent) for a long time. 99mTc product, which could be eluted from the generator with little volume, is of high radionuclidic and radiochemical purity, thus suitable for the labeling study. With the labeling efficiency and radiochemical purity both reaching more than 96 percent, 99mTc product was used for preparation of radiopharmaceuticals.

It is worth mentioning that a very efficient way to recycle 100/98Mo with a high total recovery yield of about 95 percent was realized in the work. In addition, absorption mechanism results indicated that Mo ions reacts strongly with γ-Al2O3 and a hydroxyl on the surface of HMMA, simultaneously.

According to the study, the preparation of HMMA is easy, efficient and economical, and is suited for large-scale fabrication of LSA 99Mo/99mTc . This study lays important foundation for the accelerator/reactors-based 99Mo production.

The study has been published in Applied Radiation and Isotopes and it was financially supported by the National Natural Science Foundation of China and competitive projects of the special fund for the guidance of the innovation and development of science and technology, Gansu Province.

More information: Jieru Wang et al, Practicality of hierarchically macro/mesoporous γ-Al2O3 as a promising sorbent in the preparation of low specific activity 99Mo/99mTc generator, Applied Radiation and Isotopes (2021). DOI: 10.1016/j.apradiso.2021.109986

Citation: New method to prepare diagnostic medical radioisotope (2021, November 2) retrieved 29 March 2024 from https://phys.org/news/2021-11-method-diagnostic-medical-radioisotope.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Novel tracer developed for precision targeting of non-small cell lung cancer

19 shares

Feedback to editors